DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment | MicrobiomeTrials← Back to trialsNCT06075953
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-02-17Est. Completion: 2028-11
Enrollment target: 400 participants Locations- Berkeley Outpatient Center, Berkeley, California, United States
- City of Hope -Duarte Cancer Center, Duarte, California, United States
- City of Hope - Lennar Foundation Cancer Center, Irvine, California, United States
- UCLA, Los Angeles, California, United States
- UCSF, San Francisco, California, United States
- City of Hope, South Pasadena, California, United States
- John Muir Health, Walnut Creek, California, United States
- MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
- University of Chicago Medical Center, Chicago, Illinois, United States
- Maple Grove Cancer Center, Maple Grove, Minnesota, United States
- Hennepin Healthcare -Minneapolis, Minneapolis, Minnesota, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Health Partners - Frauenshuh Cancer Center, Saint Louis Park, Minnesota, United States
- Health Partners - Regions Hospital, Saint Paul, Minnesota, United States
Other microbiome trials you might be interested in
CancerGeneral Research Use
Background:
The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health ca…
Denver, United StatesEst. completion Dec 31, 2070
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast CarcinomaMultifocal Breast CarcinomaSynchronous Bilateral Breast Carcinoma
This randomized phase III clinical trial studies how well tamoxifen citrate, anastrozole, letrozole, or exemestane with …
Anniston, United States
Englewood Hospital and Medical Center, Englewood, New Jersey, United StatesMount Sinai Union Square, New York, New York, United StatesMount Sinai Chelsea, New York, New York, United StatesMount Sinai West, New York, New York, United StatesIcahn School of Medicine at Mount Sinai, New York, New York, United StatesMontefiore Medical Center (Hutchinson Campus Tower 1), The Bronx, New York, United StatesDuke Cancer Institute, Durham, North Carolina, United StatesAtrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United StatesBryn Mawr Hospital, Bryn Mawr, Pennsylvania, United StatesPaoli Hospital, Paoli, Pennsylvania, United StatesLankenau Medical Center, Wynnewood, Pennsylvania, United StatesVanderbilt University Medical Center, Nashville, Tennessee, United StatesHuntsman Cancer Institute, Salt Lake City, Utah, United StatesVirginia Commonwealth University, Richmond, Virginia, United StatesEst. completion Feb 1, 2023